CN101506354B - 用胚胎干细胞制备转基因禽类的方法 - Google Patents
用胚胎干细胞制备转基因禽类的方法 Download PDFInfo
- Publication number
- CN101506354B CN101506354B CN200780031230.2A CN200780031230A CN101506354B CN 101506354 B CN101506354 B CN 101506354B CN 200780031230 A CN200780031230 A CN 200780031230A CN 101506354 B CN101506354 B CN 101506354B
- Authority
- CN
- China
- Prior art keywords
- cell
- stem cell
- embryonic stem
- chicken
- embryo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims abstract description 81
- 210000001671 embryonic stem cell Anatomy 0.000 title claims description 162
- 241000271566 Aves Species 0.000 title abstract description 21
- 230000009261 transgenic effect Effects 0.000 title description 16
- 238000004519 manufacturing process Methods 0.000 title description 5
- 210000002966 serum Anatomy 0.000 claims abstract description 57
- 108010005939 Ciliary Neurotrophic Factor Proteins 0.000 claims abstract description 50
- 102100031614 Ciliary neurotrophic factor Human genes 0.000 claims abstract description 50
- 108010038501 Interleukin-6 Receptors Proteins 0.000 claims abstract description 49
- 102000004889 Interleukin-6 Human genes 0.000 claims abstract description 45
- 108090001005 Interleukin-6 Proteins 0.000 claims abstract description 44
- 102000018233 Fibroblast Growth Factor Human genes 0.000 claims abstract description 43
- 229940126864 fibroblast growth factor Drugs 0.000 claims abstract description 43
- 108050007372 Fibroblast Growth Factor Proteins 0.000 claims abstract description 42
- 229940100601 interleukin-6 Drugs 0.000 claims abstract description 42
- 241001465754 Metazoa Species 0.000 claims abstract description 39
- 210000000130 stem cell Anatomy 0.000 claims abstract description 20
- 102000003815 Interleukin-11 Human genes 0.000 claims abstract description 17
- 108090000177 Interleukin-11 Proteins 0.000 claims abstract description 17
- 229940074383 interleukin-11 Drugs 0.000 claims abstract description 17
- 102000010781 Interleukin-6 Receptors Human genes 0.000 claims abstract 6
- 241000287828 Gallus gallus Species 0.000 claims description 120
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 claims description 39
- 102000013275 Somatomedins Human genes 0.000 claims description 39
- 241000272525 Anas platyrhynchos Species 0.000 claims description 37
- 108010000912 Egg Proteins Proteins 0.000 claims description 37
- 102000002322 Egg Proteins Human genes 0.000 claims description 37
- 210000004681 ovum Anatomy 0.000 claims description 35
- 238000012239 gene modification Methods 0.000 claims description 23
- 230000005017 genetic modification Effects 0.000 claims description 23
- 235000013617 genetically modified food Nutrition 0.000 claims description 23
- 230000004720 fertilization Effects 0.000 claims description 14
- 238000001890 transfection Methods 0.000 claims description 13
- 210000002216 heart Anatomy 0.000 claims description 11
- -1 STEM CELL FACTOR Proteins 0.000 claims description 10
- 235000015097 nutrients Nutrition 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 8
- 210000002298 blastodisc Anatomy 0.000 claims description 6
- 239000004615 ingredient Substances 0.000 claims description 5
- 239000006285 cell suspension Substances 0.000 claims 2
- 108091008794 FGF receptors Proteins 0.000 claims 1
- 102000016971 Proto-Oncogene Proteins c-kit Human genes 0.000 claims 1
- 108010014608 Proto-Oncogene Proteins c-kit Proteins 0.000 claims 1
- 210000004027 cell Anatomy 0.000 abstract description 236
- 239000002609 medium Substances 0.000 abstract description 47
- 102100037852 Insulin-like growth factor I Human genes 0.000 abstract description 32
- 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 abstract description 30
- 238000012258 culturing Methods 0.000 abstract description 12
- 239000003102 growth factor Substances 0.000 abstract description 8
- 230000002401 inhibitory effect Effects 0.000 abstract description 7
- 208000032839 leukemia Diseases 0.000 abstract description 7
- 239000000725 suspension Substances 0.000 abstract description 7
- 239000001963 growth medium Substances 0.000 abstract description 3
- 210000001172 blastoderm Anatomy 0.000 abstract description 2
- 101150101999 IL6 gene Proteins 0.000 abstract 2
- 238000010899 nucleation Methods 0.000 abstract 1
- 235000013330 chicken meat Nutrition 0.000 description 118
- 210000001161 mammalian embryo Anatomy 0.000 description 117
- 239000010410 layer Substances 0.000 description 74
- 102100037792 Interleukin-6 receptor subunit alpha Human genes 0.000 description 41
- 235000014676 Phragmites communis Nutrition 0.000 description 34
- 108020004414 DNA Proteins 0.000 description 29
- 239000003550 marker Substances 0.000 description 27
- 238000005516 engineering process Methods 0.000 description 25
- 108090000623 proteins and genes Proteins 0.000 description 20
- 230000012447 hatching Effects 0.000 description 19
- 244000309466 calf Species 0.000 description 18
- 210000003746 feather Anatomy 0.000 description 18
- 230000002441 reversible effect Effects 0.000 description 18
- 210000004602 germ cell Anatomy 0.000 description 17
- 239000011159 matrix material Substances 0.000 description 16
- 238000004458 analytical method Methods 0.000 description 14
- 230000004069 differentiation Effects 0.000 description 14
- 238000002347 injection Methods 0.000 description 14
- 239000007924 injection Substances 0.000 description 14
- 102000004169 proteins and genes Human genes 0.000 description 14
- 210000001519 tissue Anatomy 0.000 description 14
- 230000003321 amplification Effects 0.000 description 13
- 238000000338 in vitro Methods 0.000 description 13
- 238000003199 nucleic acid amplification method Methods 0.000 description 13
- 230000008569 process Effects 0.000 description 13
- 230000000392 somatic effect Effects 0.000 description 13
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 12
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 12
- 108090000765 processed proteins & peptides Proteins 0.000 description 12
- 230000001568 sexual effect Effects 0.000 description 12
- 239000011734 sodium Substances 0.000 description 12
- 229910052708 sodium Inorganic materials 0.000 description 12
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 12
- 241000286209 Phasianidae Species 0.000 description 11
- 239000003797 essential amino acid Substances 0.000 description 11
- 238000003752 polymerase chain reaction Methods 0.000 description 11
- 229920001184 polypeptide Polymers 0.000 description 11
- 102000004196 processed proteins & peptides Human genes 0.000 description 11
- 101100263436 Drosophila melanogaster vas gene Proteins 0.000 description 10
- 101100049051 Penaeus vannamei vasa gene Proteins 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 235000020776 essential amino acid Nutrition 0.000 description 10
- 230000012010 growth Effects 0.000 description 10
- 108020004707 nucleic acids Proteins 0.000 description 10
- 102000039446 nucleic acids Human genes 0.000 description 10
- 150000007523 nucleic acids Chemical class 0.000 description 10
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 10
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 9
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 9
- 244000258136 Costus speciosus Species 0.000 description 9
- 235000000385 Costus speciosus Nutrition 0.000 description 9
- 239000012634 fragment Substances 0.000 description 9
- 210000004907 gland Anatomy 0.000 description 9
- 230000008676 import Effects 0.000 description 9
- 238000011534 incubation Methods 0.000 description 9
- LAQPKDLYOBZWBT-NYLDSJSYSA-N (2s,4s,5r,6r)-5-acetamido-2-{[(2s,3r,4s,5s,6r)-2-{[(2r,3r,4r,5r)-5-acetamido-1,2-dihydroxy-6-oxo-4-{[(2s,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}hexan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-4-hydroxy-6-[(1r,2r)-1,2,3-trihydrox Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]([C@@H](NC(C)=O)C=O)[C@@H]([C@H](O)CO)O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O)[C@@H](CO)O1 LAQPKDLYOBZWBT-NYLDSJSYSA-N 0.000 description 8
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 8
- 206010068052 Mosaicism Diseases 0.000 description 8
- 108091034117 Oligonucleotide Proteins 0.000 description 8
- 238000011161 development Methods 0.000 description 8
- 230000018109 developmental process Effects 0.000 description 8
- 238000000926 separation method Methods 0.000 description 8
- 102220575132 Leucine-rich repeat transmembrane protein FLRT1_S86N_mutation Human genes 0.000 description 7
- 210000002969 egg yolk Anatomy 0.000 description 7
- 108091008146 restriction endonucleases Proteins 0.000 description 7
- 238000012546 transfer Methods 0.000 description 7
- 241000272814 Anser sp. Species 0.000 description 6
- 102000004127 Cytokines Human genes 0.000 description 6
- 108090000695 Cytokines Proteins 0.000 description 6
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 6
- 101150052863 THY1 gene Proteins 0.000 description 6
- 239000003636 conditioned culture medium Substances 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 6
- 230000001678 irradiating effect Effects 0.000 description 6
- 244000144977 poultry Species 0.000 description 6
- 235000013594 poultry meat Nutrition 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 238000000123 temperature gradient gel electrophoresis Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 241000283073 Equus caballus Species 0.000 description 5
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 5
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 5
- 239000002771 cell marker Substances 0.000 description 5
- 210000002257 embryonic structure Anatomy 0.000 description 5
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 230000007774 longterm Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 238000003757 reverse transcription PCR Methods 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 239000013589 supplement Substances 0.000 description 5
- 230000004083 survival effect Effects 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- 108700028369 Alleles Proteins 0.000 description 4
- 241000713826 Avian leukosis virus Species 0.000 description 4
- 241000272201 Columbiformes Species 0.000 description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 229940041514 candida albicans extract Drugs 0.000 description 4
- 230000010261 cell growth Effects 0.000 description 4
- 210000004748 cultured cell Anatomy 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 230000008034 disappearance Effects 0.000 description 4
- 238000011081 inoculation Methods 0.000 description 4
- 230000010354 integration Effects 0.000 description 4
- 210000002752 melanocyte Anatomy 0.000 description 4
- 239000013612 plasmid Substances 0.000 description 4
- 210000000582 semen Anatomy 0.000 description 4
- 210000000998 shell membrane Anatomy 0.000 description 4
- 239000013598 vector Substances 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 239000012138 yeast extract Substances 0.000 description 4
- 102000016989 Ciliary Neurotrophic Factor Receptor Human genes 0.000 description 3
- 108010000063 Ciliary Neurotrophic Factor Receptor Proteins 0.000 description 3
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 3
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 3
- 241000272496 Galliformes Species 0.000 description 3
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- HPFXACZRFJDURI-KTKRTIGZSA-N N-oleoylglycine Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)NCC(O)=O HPFXACZRFJDURI-KTKRTIGZSA-N 0.000 description 3
- 238000012408 PCR amplification Methods 0.000 description 3
- 229930182555 Penicillin Natural products 0.000 description 3
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 3
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 3
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 3
- 241000220010 Rhode Species 0.000 description 3
- 108010017842 Telomerase Proteins 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 238000004043 dyeing Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000013604 expression vector Substances 0.000 description 3
- 210000002744 extracellular matrix Anatomy 0.000 description 3
- 230000002779 inactivation Effects 0.000 description 3
- 238000012423 maintenance Methods 0.000 description 3
- 230000013011 mating Effects 0.000 description 3
- 239000012913 medium supplement Substances 0.000 description 3
- 210000003716 mesoderm Anatomy 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 230000000394 mitotic effect Effects 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000000877 morphologic effect Effects 0.000 description 3
- 210000001982 neural crest cell Anatomy 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 235000003170 nutritional factors Nutrition 0.000 description 3
- 230000032696 parturition Effects 0.000 description 3
- 229940049954 penicillin Drugs 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 102000005962 receptors Human genes 0.000 description 3
- 108020003175 receptors Proteins 0.000 description 3
- 238000010361 transduction Methods 0.000 description 3
- 230000026683 transduction Effects 0.000 description 3
- 101150089602 vasa gene Proteins 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 description 2
- 108091093088 Amplicon Proteins 0.000 description 2
- 241000272517 Anseriformes Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241000186810 Erysipelothrix rhusiopathiae Species 0.000 description 2
- 241000576858 Fraxinus dipetala Species 0.000 description 2
- 101000599048 Homo sapiens Interleukin-6 receptor subunit alpha Proteins 0.000 description 2
- 108010031794 IGF Type 1 Receptor Proteins 0.000 description 2
- 241000351643 Metapneumovirus Species 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 108010064983 Ovomucin Proteins 0.000 description 2
- 241001165859 Perdicinae Species 0.000 description 2
- 108010059712 Pronase Proteins 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000282898 Sus scrofa Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 210000001136 chorion Anatomy 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 238000003935 denaturing gradient gel electrophoresis Methods 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 210000002308 embryonic cell Anatomy 0.000 description 2
- 230000008175 fetal development Effects 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 210000002149 gonad Anatomy 0.000 description 2
- 235000015220 hamburgers Nutrition 0.000 description 2
- 230000006801 homologous recombination Effects 0.000 description 2
- 238000002744 homologous recombination Methods 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 238000001638 lipofection Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 238000000520 microinjection Methods 0.000 description 2
- 230000004660 morphological change Effects 0.000 description 2
- 210000000287 oocyte Anatomy 0.000 description 2
- RLZZZVKAURTHCP-UHFFFAOYSA-N phenanthrene-3,4-diol Chemical compound C1=CC=C2C3=C(O)C(O)=CC=C3C=CC2=C1 RLZZZVKAURTHCP-UHFFFAOYSA-N 0.000 description 2
- 238000004080 punching Methods 0.000 description 2
- 230000033458 reproduction Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000005204 segregation Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000003153 stable transfection Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- QTENRWWVYAAPBI-YCRXJPFRSA-N streptomycin sulfate Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O QTENRWWVYAAPBI-YCRXJPFRSA-N 0.000 description 2
- 230000009182 swimming Effects 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- NWXMGUDVXFXRIG-WESIUVDSSA-N (4s,4as,5as,6s,12ar)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O NWXMGUDVXFXRIG-WESIUVDSSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- QRXMUCSWCMTJGU-UHFFFAOYSA-N 5-bromo-4-chloro-3-indolyl phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP(O)(=O)O)=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-N 0.000 description 1
- 102100027211 Albumin Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 241000272521 Anatidae Species 0.000 description 1
- 241000272518 Anhimidae Species 0.000 description 1
- 241000193085 Anseranatidae Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000271558 Casuarius casuarius Species 0.000 description 1
- 241000251477 Chimaera Species 0.000 description 1
- 241000251556 Chordata Species 0.000 description 1
- 241001232809 Chorista Species 0.000 description 1
- 108010026206 Conalbumin Proteins 0.000 description 1
- 241000334119 Coturnix japonica Species 0.000 description 1
- 206010011469 Crying Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 241000271571 Dromaius novaehollandiae Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108091092584 GDNA Proteins 0.000 description 1
- 241000287826 Gallus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 101000993364 Homo sapiens Ciliary neurotrophic factor Proteins 0.000 description 1
- 101001052035 Homo sapiens Fibroblast growth factor 2 Proteins 0.000 description 1
- 101000976075 Homo sapiens Insulin Proteins 0.000 description 1
- 101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 description 1
- 101150088952 IGF1 gene Proteins 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 1
- 108010064696 N,O-diacetylmuramidase Proteins 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 241000287127 Passeridae Species 0.000 description 1
- 206010034107 Pasteurella infections Diseases 0.000 description 1
- 241000287531 Psittacidae Species 0.000 description 1
- 238000010802 RNA extraction kit Methods 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 238000010240 RT-PCR analysis Methods 0.000 description 1
- 241001478212 Riemerella anatipestifer Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 241001665167 Solter Species 0.000 description 1
- 241000272534 Struthio camelus Species 0.000 description 1
- 102100038126 Tenascin Human genes 0.000 description 1
- 108010008125 Tenascin Proteins 0.000 description 1
- 102100033523 Thy-1 membrane glycoprotein Human genes 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000003167 anti-vitamin Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 210000002459 blastocyst Anatomy 0.000 description 1
- 210000000625 blastula Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 230000034303 cell budding Effects 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000003837 chick embryo Anatomy 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 210000003981 ectoderm Anatomy 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 244000144992 flock Species 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- PGBHMTALBVVCIT-VCIWKGPPSA-N framycetin Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)N)O[C@@H]1CO PGBHMTALBVVCIT-VCIWKGPPSA-N 0.000 description 1
- 230000005251 gamma ray Effects 0.000 description 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000002710 gonadal effect Effects 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 239000000833 heterodimer Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000012376 hot air sterilization Methods 0.000 description 1
- 210000004408 hybridoma Anatomy 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 230000009027 insemination Effects 0.000 description 1
- PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 description 1
- 230000002608 insulinlike Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012533 medium component Substances 0.000 description 1
- 210000003866 melanoblast Anatomy 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 230000029052 metamorphosis Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000017448 oviposition Effects 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 201000005115 pasteurellosis Diseases 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000012679 serum free medium Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000012192 staining solution Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 238000005987 sulfurization reaction Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001694 thigh bone Anatomy 0.000 description 1
- 238000004454 trace mineral analysis Methods 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
- 210000001534 vitelline membrane Anatomy 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 239000012463 white pigment Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/30—Bird
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/105—Insulin-like growth factors [IGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/13—Nerve growth factor [NGF]; Brain-derived neurotrophic factor [BDNF]; Cilliary neurotrophic factor [CNTF]; Glial-derived neurotrophic factor [GDNF]; Neurotrophins [NT]; Neuregulins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2306—Interleukin-6 (IL-6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Environmental Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83637806P | 2006-08-09 | 2006-08-09 | |
| US60/836,378 | 2006-08-09 | ||
| PCT/EP2007/058263 WO2008017704A1 (en) | 2006-08-09 | 2007-08-09 | Method of production of transgenic avian using embryonic stem cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101506354A CN101506354A (zh) | 2009-08-12 |
| CN101506354B true CN101506354B (zh) | 2014-05-07 |
Family
ID=38752394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200780031230.2A Expired - Fee Related CN101506354B (zh) | 2006-08-09 | 2007-08-09 | 用胚胎干细胞制备转基因禽类的方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US8962311B2 (ru) |
| EP (2) | EP2054507A1 (ru) |
| JP (1) | JP5405302B2 (ru) |
| KR (1) | KR101567095B1 (ru) |
| CN (1) | CN101506354B (ru) |
| AU (1) | AU2007283564B2 (ru) |
| BR (1) | BRPI0714257A8 (ru) |
| CA (1) | CA2660035A1 (ru) |
| MX (1) | MX2009001477A (ru) |
| NZ (1) | NZ574678A (ru) |
| RU (1) | RU2473688C2 (ru) |
| WO (1) | WO2008017704A1 (ru) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2836924B1 (fr) * | 2002-03-08 | 2005-01-14 | Vivalis | Lignees de cellules aviaires utiles pour la production de substances d'interet |
| EP1985305A1 (en) | 2007-04-24 | 2008-10-29 | Vivalis | Duck embryonic derived stem cell lines for the production of viral vaccines |
| EP2100954A1 (en) * | 2008-03-10 | 2009-09-16 | Assistance Publique - Hopitaux de Paris | Method for generating primate cardiac progenitor cells for clinical use from primate embryonic stem cells, and their applications |
| CA2800534C (en) | 2010-06-11 | 2019-01-22 | Regeneron Pharmaceuticals, Inc. | Production of fertile xy female animals from xy es cells |
| EP2883951B1 (en) * | 2012-06-15 | 2018-01-17 | Kyokuto Pharmaceutical Industrial Co. Ltd | Stem cell preservation medium, stem cell preservation method, and stem cell preservation system |
| US20140255447A1 (en) * | 2013-03-05 | 2014-09-11 | Biomune Company | Production of avian embryo cells |
| KR101588109B1 (ko) * | 2014-03-06 | 2016-01-25 | 건국대학교 산학협력단 | 키메라를 이용한 유도만능줄기세포 유래 체내 신경줄기세포 생산 방법 |
| MX2016017317A (es) | 2014-06-26 | 2017-08-24 | Regeneron Pharma | Metodos y composiciones para modificaciones geneticas dirigidas y metodos de uso. |
| US20200224156A1 (en) * | 2015-09-09 | 2020-07-16 | Cryogenetics As | Method for removal of yolk |
| US10893666B2 (en) | 2015-09-17 | 2021-01-19 | Regeneron Pharmaceuticals, Inc. | Production of fertile XY female animals by silencing of genes on the Y chromosome |
| US20170258495A1 (en) * | 2016-02-29 | 2017-09-14 | The Curators Of The University Of Missouri | Medium supplement to increase the efficiency of oocyte maturation and embryo culture in vitro |
| CN108004197B (zh) * | 2017-12-14 | 2021-06-08 | 浙江海洋大学 | 一种乌贼胚胎细胞的原代培养方法及专有试剂 |
| CN108782458B (zh) * | 2018-07-02 | 2022-02-11 | 江苏威特凯鸽业有限公司 | 一种改良泰深鸽的培育方法 |
| CN110283779A (zh) * | 2019-07-17 | 2019-09-27 | 吉林省农业科学院 | 一种鸡胚胎干细胞的分离培养方法及培养基 |
| CN112251399B (zh) * | 2020-10-21 | 2022-12-09 | 中国科学院水生生物研究所 | 一种用于黄鳝生殖干细胞的分离方法及培养基 |
| CN114350599B (zh) * | 2022-01-14 | 2024-01-19 | 内蒙古大学 | 一种增强牛胚胎干细胞的多能性和代谢活力的培养体系和培养方法 |
| CN115088679A (zh) * | 2022-07-20 | 2022-09-23 | 扬州大学 | 一种利用性腺细胞构建嵌合体鸡保种的方法 |
| CN116210647A (zh) * | 2023-02-03 | 2023-06-06 | 威奥福生物科技(宁波)有限公司 | 一种使用原始生殖细胞干细胞系扩繁白羽肉鸡的方法 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU623922B2 (en) | 1988-08-04 | 1992-05-28 | Amrad Operations Pty. Limited | In vitro propagation of embryonic stem cells |
| US5162215A (en) * | 1988-09-22 | 1992-11-10 | Amgen Inc. | Method of gene transfer into chickens and other avian species |
| JPH05227947A (ja) | 1992-01-14 | 1993-09-07 | Rikagaku Kenkyusho | 鳥類原始生殖細胞の分離方法 |
| AU3597093A (en) | 1992-01-27 | 1993-09-01 | Embrex Inc. | Gene transfer in poultry by introduction of embryo cells (in ovo) |
| US5340740A (en) | 1992-05-15 | 1994-08-23 | North Carolina State University | Method of producing an avian embryonic stem cell culture and the avian embryonic stem cell culture produced by the process |
| WO1994003585A1 (en) | 1992-08-04 | 1994-02-17 | Commonwealth Scientific And Industrial Research Organisation | A method for maintaining embryonic stem cells and avian factor useful for same |
| US5453357A (en) * | 1992-10-08 | 1995-09-26 | Vanderbilt University | Pluripotential embryonic stem cells and methods of making same |
| US5589458A (en) * | 1992-11-13 | 1996-12-31 | Thomas Jefferson University | Compounds that inhibit T cell proliferation and methods for using the same |
| FR2726003B1 (fr) | 1994-10-21 | 2002-10-18 | Agronomique Inst Nat Rech | Milieu de culture de cellules embryonnaires totipotentes aviaires, procede de culture de ces cellules, et cellules embryonnaires totipotentes aviaires |
| JPH0924997A (ja) | 1995-07-11 | 1997-01-28 | Tokico Ltd | 出荷装置 |
| US6103529A (en) | 1996-10-10 | 2000-08-15 | Life Technologies, Inc. | Animal cell culture media comprising peptides derived from rice |
| PT841392E (pt) | 1996-11-12 | 2004-11-30 | Univ Auburn | Vacina viva atenuada de neospora |
| CA2300336A1 (en) | 1997-08-04 | 1999-02-11 | University Of Massachusetts A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus | Production of avian embryonic germ (eg) cell lines by prolonged culturing of pgcs, use thereof for cloning and chimerization |
| BR9811830A (pt) | 1997-08-04 | 2000-08-15 | Univ Massachusetts | Processo de cultivo que proporciona manutenção de células germinais primitivas de ave por perìodos prolongados, processo de produção de aves quiméricas, e, linhagem celular de pgc de ave |
| US6406909B1 (en) | 1998-07-10 | 2002-06-18 | Chugai Seiyaku Kabushiki Kaisha | Serum-free medium for culturing animal cells |
| DE60037107T2 (de) | 1999-02-11 | 2008-09-25 | Hanmi Pharm. Co., Ltd. | Pluripotente embryonale keimzellinie aus vögeln |
| DE19947407C2 (de) | 1999-10-01 | 2002-08-01 | Bayerische Motoren Werke Ag | Datenbussystem für Kraftfahrzeuge |
| WO2003043414A1 (en) | 2001-11-16 | 2003-05-30 | Australian Water Management Pty Ltd | A method of treating a target species of fish within a general fish population |
| FR2836924B1 (fr) * | 2002-03-08 | 2005-01-14 | Vivalis | Lignees de cellules aviaires utiles pour la production de substances d'interet |
| JP2005532057A (ja) * | 2002-07-09 | 2005-10-27 | バクスター・インターナショナル・インコーポレイテッド | 細胞を培養するための動物性タンパク質非含有培地 |
| EP1500699A1 (en) | 2003-07-22 | 2005-01-26 | Vivalis | Production of vaccinia virus with adherent or non adherent avian cell lines |
| EP1646715B1 (en) * | 2003-07-22 | 2010-05-12 | Vivalis | Production of poxviruses with adherent or non adherent avian cell lines |
| FR2884255B1 (fr) * | 2005-04-11 | 2010-11-05 | Vivalis | Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe |
| WO2007135133A1 (en) | 2006-05-19 | 2007-11-29 | Vivalis | Avian cell lines derived from primordial germ cells useful for the production of substances of interest |
| EP1985305A1 (en) * | 2007-04-24 | 2008-10-29 | Vivalis | Duck embryonic derived stem cell lines for the production of viral vaccines |
-
2007
- 2007-08-09 WO PCT/EP2007/058263 patent/WO2008017704A1/en active Application Filing
- 2007-08-09 RU RU2009107854/10A patent/RU2473688C2/ru not_active IP Right Cessation
- 2007-08-09 MX MX2009001477A patent/MX2009001477A/es active IP Right Grant
- 2007-08-09 AU AU2007283564A patent/AU2007283564B2/en not_active Ceased
- 2007-08-09 BR BRPI0714257A patent/BRPI0714257A8/pt not_active IP Right Cessation
- 2007-08-09 CA CA002660035A patent/CA2660035A1/en not_active Abandoned
- 2007-08-09 JP JP2009523296A patent/JP5405302B2/ja not_active Expired - Fee Related
- 2007-08-09 US US12/376,660 patent/US8962311B2/en active Active
- 2007-08-09 EP EP07802553A patent/EP2054507A1/en not_active Withdrawn
- 2007-08-09 CN CN200780031230.2A patent/CN101506354B/zh not_active Expired - Fee Related
- 2007-08-09 EP EP12167371A patent/EP2500417A1/en not_active Withdrawn
- 2007-08-09 NZ NZ574678A patent/NZ574678A/en not_active IP Right Cessation
- 2007-08-09 KR KR1020097003555A patent/KR101567095B1/ko not_active IP Right Cessation
-
2014
- 2014-12-30 US US14/585,955 patent/US20150225695A1/en not_active Abandoned
Non-Patent Citations (2)
| Title |
|---|
| B.Pain.long-term in vitro culture and characterisation of avian embryonic stem cells with multiple morohogenetic potentialities.《development》.1996,第122卷2339-2348. * |
| pierrich thoraval,等.germline transmission of exogenous genes in chickens using helper-free ecotropic avian leukosis virus-based vectors.《transgenic research》.1995,第4卷369-376. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2660035A1 (en) | 2008-02-14 |
| RU2009107854A (ru) | 2010-09-27 |
| MX2009001477A (es) | 2009-02-18 |
| EP2500417A1 (en) | 2012-09-19 |
| BRPI0714257A8 (pt) | 2017-05-09 |
| JP2010500015A (ja) | 2010-01-07 |
| AU2007283564A1 (en) | 2008-02-14 |
| AU2007283564B2 (en) | 2013-07-25 |
| KR101567095B1 (ko) | 2015-11-06 |
| US8962311B2 (en) | 2015-02-24 |
| KR20090038464A (ko) | 2009-04-20 |
| RU2473688C2 (ru) | 2013-01-27 |
| NZ574678A (en) | 2012-03-30 |
| US20150225695A1 (en) | 2015-08-13 |
| WO2008017704A1 (en) | 2008-02-14 |
| JP5405302B2 (ja) | 2014-02-05 |
| EP2054507A1 (en) | 2009-05-06 |
| US20100235937A1 (en) | 2010-09-16 |
| BRPI0714257A2 (pt) | 2013-12-03 |
| CN101506354A (zh) | 2009-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101506354B (zh) | 用胚胎干细胞制备转基因禽类的方法 | |
| Nakamura et al. | Development, differentiation and manipulation of chicken germ cells | |
| Kagami et al. | The developmental origin of primordial germ cells and the transmission of the donor‐derived gametes in mixed‐sex germline chimeras to the offspring in the chicken | |
| Petitte et al. | Accessing the genome of the chicken using germline chimeras | |
| CN100386429C (zh) | 鸟类多能胚胎生殖细胞系 | |
| EP1149899A1 (fr) | Milieu de culture de cellules embryonnaires totipotentes aviaires | |
| US20140127812A1 (en) | Long-term culture of avian primordial germ cells (pgcs) | |
| Chen et al. | In vitro culture and characterization of duck primordial germ cells | |
| Bednarczyk et al. | Improvement of hatchability of chicken eggs injected by blastoderm cells | |
| JP2007501625A (ja) | 鳥類精原幹細胞の培養方法及びこれにより収得した鳥類精原幹細胞 | |
| US7476776B2 (en) | Method for improving germline transmission efficiency of avian primordial germ cells | |
| NAITO | Development of avian embryo manipulation techniques and their application to germ cell manipulation | |
| WO2016091385A1 (en) | System and method for establishing a long-term culture of avian primordial germ cells and uses thereof | |
| US20020162134A1 (en) | Primordial germ cell-based germ line production of birds | |
| JP2005507234A (ja) | 始原生殖細胞ベースの、鳥の生殖細胞系の作製 | |
| Naito | Genetic manipulation in chickens | |
| Kozikova et al. | Phenotypic Features of the Chicken Chimeras Obtained by Transplantation of Blastoderm Cells of the Russian White, New Hampshire and Australorp Black Breeds | |
| Singh et al. | Technological developments in the poultry subsector | |
| Tirawattanawanich | Conservation of Red Junglefowl Biodiversity by Primordial Germ Cell Cryopreservation | |
| Inada et al. | In vivo gene transfer to chicken via blastodermal cells of early developmental embryos | |
| Bernardino et al. | Isolation and characterization of gonadal primordial germ cells (gPGCs) of turkey (Meleagris gallopavo) from 11-14 days old embryos. | |
| 한재용 et al. | Expression of Lac Z gene in young chick gonad by the transfected primordial germ cell injection | |
| Li et al. | Research of blastocyte-like structure in chicken | |
| Matsubara et al. | A simple culture method of chicken blastodermal cells for germline transmission | |
| AU2002253850A1 (en) | Primordial germ cell-based germ line production of birds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C53 | Correction of patent of invention or patent application | ||
| CB02 | Change of applicant information |
Address after: lyon Applicant after: VIVALIS Address before: West France Applicant before: Vivalis |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: VIVALIS TO: VALNEVA GMBH |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CI01 | Publication of corrected invention patent application |
Correction item: Address of the patentee Correct: lyon False: Li Ang Number: 19 Volume: 30 |
|
| CI03 | Correction of invention patent |
Correction item: Address of the patentee Correct: lyon False: Li Ang Number: 19 Page: The title page Volume: 30 |
|
| ERR | Gazette correction |
Free format text: DELETE PATENTEE ADDRESS; FROM: LYON |
|
| RECT | Rectification | ||
| C53 | Correction of patent of invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Valarche Isabelle Inventor after: Batard Luc Inventor after: Mehtali Majid Inventor after: F guehennec Inventor before: Valarche Isabelle Inventor before: Batard Luc Inventor before: Mehtali Majid |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: ISABELLE VALARCHE LUC BATARD MAJID MEHTALI TO: ISABELLE VALARCHE LUC BATARD MAJID MEHTALI F. GUEHENNEC |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140507 Termination date: 20160809 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |